AU5124500A - Tumor necrosis factor-gamma - Google Patents

Tumor necrosis factor-gamma

Info

Publication number
AU5124500A
AU5124500A AU51245/00A AU5124500A AU5124500A AU 5124500 A AU5124500 A AU 5124500A AU 51245/00 A AU51245/00 A AU 51245/00A AU 5124500 A AU5124500 A AU 5124500A AU 5124500 A AU5124500 A AU 5124500A
Authority
AU
Australia
Prior art keywords
gamma
necrosis factor
tumor necrosis
tumor
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51245/00A
Inventor
Jian Ni
Craig A Rosen
Guo-Liang Yu
Jun Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU5124500A publication Critical patent/AU5124500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU51245/00A 1999-04-30 2000-04-28 Tumor necrosis factor-gamma Abandoned AU5124500A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US13196399P 1999-04-30 1999-04-30
US60131963 1999-04-30
US13222799P 1999-05-03 1999-05-03
US60132227 1999-05-03
US13406799P 1999-05-13 1999-05-13
US60134067 1999-05-13
US18090800P 2000-02-08 2000-02-08
US60180908 2000-02-08
PCT/US2000/011689 WO2000066608A1 (en) 1999-04-30 2000-04-28 Tumor necrosis factor-gamma

Publications (1)

Publication Number Publication Date
AU5124500A true AU5124500A (en) 2000-11-17

Family

ID=27494940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51245/00A Abandoned AU5124500A (en) 1999-04-30 2000-04-28 Tumor necrosis factor-gamma

Country Status (2)

Country Link
AU (1) AU5124500A (en)
WO (1) WO2000066608A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100398551C (en) 2001-11-09 2008-07-02 乔治敦大学 Novel isoforms of vascular endothelial cell growth inhibitor
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
BR112015024752A2 (en) 2013-03-27 2017-07-18 Cedars Sinai Medical Center mitigation and reversal of fibrosis and inflammation through inhibition of tl1a function and related signaling pathways
WO2015010108A1 (en) 2013-07-19 2015-01-22 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
US11186872B2 (en) 2016-03-17 2021-11-30 Cedars-Sinai Medical Center Methods of diagnosing inflammatory bowel disease through RNASET2
US10322174B2 (en) 2016-10-26 2019-06-18 Cedars-Sinai Medical Center Neutralizing anti-TL1A monoclonal antibodies
CN112585165A (en) 2018-04-25 2021-03-30 普罗米修斯生物科学公司 Optimized anti-TL 1A antibodies
KR20220103721A (en) 2019-10-24 2022-07-22 프로메테우스 바이오사이언시즈, 인크. Humanized Antibodies to TNF-Like Ligand 1A (TL1A) and Uses Thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2067821A1 (en) * 1989-10-24 1991-04-25 Cetus Oncology Corporation Infective drug delivery system using recombinant retroviral vectors
AU708972B2 (en) * 1994-11-07 1999-08-19 Human Genome Sciences, Inc. Tumor necrosis factor-gamma

Also Published As

Publication number Publication date
WO2000066608A1 (en) 2000-11-09
WO2000066608A9 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU7979600A (en) Antenna means
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU1317801A (en) Dual-polarised antenna
EP1100886A4 (en) Tumor necrosis factor-gamma
AU2678800A (en) Modified calycins
AU2965600A (en) Interleukin-20
AU5967600A (en) Candystraw
AU6335000A (en) Depthimeter
AU4115400A (en) Short-circuiter
AU7514700A (en) Cyanopiperidines
AU2804600A (en) Arylaminoalkylamides
AU6440900A (en) Homogentisate-dioxygenase
AU2023701A (en) Sketcher
AU5124500A (en) Tumor necrosis factor-gamma
AU2699800A (en) Organoceramics
AU2001277857A1 (en) Tumor necrosis factor-gamma
AU3174900A (en) Antenna
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU5022400A (en) Tumor necrosis factor receptor 5
AU4561600A (en) Benzofuranylaminoalcohols
AU1901801A (en) Glucofuranoses
AU6567400A (en) Substituted 2-imino-thiazolines
AU1915601A (en) Periotome

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase